SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-13-039652
Filing Date
2013-07-16
Accepted
2013-07-16 08:49:44
Documents
3
Period of Report
2013-07-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v350064_8k.htm 8-K 21453
2 EXHIBIT 99.1 v350064_ex99-1.htm EX-99.1 15460
3 GRAPHIC image_002.jpg GRAPHIC 36724
  Complete submission text file 0001144204-13-039652.txt   88971
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 13969392
SIC: 2836 Biological Products, (No Diagnostic Substances)